-
-
-
-
-
-
-
Jefferies Starts Oruka Therapeutics (ORKA) at Buy
-
-
-
-
-
-
-
FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) Appoints Laura Sandler as COO
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
-
-
-
-
-
-
-
LifeSci Capital Starts Oruka Therapeutics (ORKA) at Outperform
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

